AMGN Latest Headlines

Analyst Holds on Amgen’s Tezspire amid COPD Trial Uncertainties and Pending Competitor Comparisons

at www.tipranks.com (Thu, 18-Apr 12:29 AM)

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

at www.benzinga.com (Wed, 17-Apr 2:39 PM)

CVS favors Humira copycats hurting AbbVie’s market share: Evercore

at seekingalpha.com (Wed, 17-Apr 9:26 AM)

Buy Rating on Amgen: Tezspire’s Market Potential in COPD Treatment Undervalued

at www.tipranks.com (Wed, 17-Apr 5:45 AM)

Barclays Keeps Their Sell Rating on Amgen (AMGN)

at www.tipranks.com (Wed, 17-Apr 3:25 AM)

As more rare disease therapies launch, their prices are rising

at seekingalpha.com (Tue, 16-Apr 12:22 PM)

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Notable Labs (NTBL)

at www.tipranks.com (Mon, 15-Apr 8:01 AM)

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)

at www.tipranks.com (Mon, 15-Apr 7:40 AM)